SIGMAR1 and Alzheimer disease: Notably, in vivo brain imaging using [11C]-SA4503 showed a reduced Sigmar1 density in the frontal, temporal, occipital lobes, cerebellum, and thalamus of early stage AD patients (Mishina et al., 2008; Toyohara et al., 2009).